retatrutide phase 2 obesity trial results just delivered one of the largest weight-loss signals we've ever seen in a medication trial. In a study: • Up to 24.2% mean weight loss at 48 weeks Eli Lilly infiltrates anti-obesity market

It is about supporting the system correctly

Poupon-Bejuit L, Hughes MP, Liu W et al (2022) A GLP1 receptor agonist diabetes drug ameliorates neurodegeneration in a mouse model of infantile neurometabolic disease

The original Achilles tendon transection model in rats (Staresinic, Sikiric et al., 2003) showed that systemic BPC-157 accelerated healing of fully transected tendons, and this finding has been reproduced across multiple labs over the 20+ years since

Based on eigengene expression patterns, CM1 was classified as signal transduction, CM2-9 as early responses, and CM10-14 as post-early responses, which were grouped into meta-modules

The formula is gluten-free, dairy-free, soy-free, non-GMO, vegetarian, and vegan